Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis.

Amir Valizadeh Mohammad Reza Fattahi Maryam Sadeghi Mehrnush Saghab Torbati Mohammad Ali Sahraian Amir Reza Azimi

Published in: CNS neuroscience & therapeutics (2022)

DMTs reduce the number and volume of T1 hypointense lesions. Although, these findings must be interpreted cautiously due to the high values of heterogeneity.

Keyphrases